▶High Reliability of Vcheck cPL 2.0 Test in Diagnosing and Monitoring Canine Pancreatitis has been published in the SCI-level international journal. Pancreatitis is a common condition in dogs associated with exocrine pancreatic dysfunction. Accurate diagnosis requires consideration of clinical history, symptoms, abdominal ultrasound, and laboratory tests. However, diagnosing pancreatitis can be challenging due to non-specific symptoms such as loss of appetite, lethargy, and vomiting. Traditional tests like CBC, biochemical tests, and ultrasound have low diagnostic specificity. A recent paper on Vcheck cPL 2.0 was published in the "Journal of Veterinary Science", an SCI journal.The study found that Vcheck cPL 2.0 closely matches the gold standard test, with near-perfect agreement (r = 0.958, p < 0.001). It also showed that the changes in serum cPL concentrations measured by both tests were highly consistent over time.※ For product-related inquiries, please contact the official distributors, Bionote Inc.,
For more information about the products, please visit the following page: Vcheck D-dimer 5Tests/Kit Bionote announced the release of its new D-dimer kit packaging in a 5-test format for its Vcheck immunodiagnostic equipment used in veterinary clinics.D-dimer is one of the degradation products formed when fibrin clots dissolve during the blood coagulation process. It serves as an indicator of the ongoing process of blood clotting and subsequent recovery in the body following tissue or vascular damage.This marker can be utilized as a valuable diagnostic tool for various diseases such as tumors, sepsis, pancreatitis, and immune-mediated diseases.Particularly, D-dimer testing, when used alongside other coagulation tests such as platelet count, PT (Prothrombin Time), and APTT (Activated Partial Thromboplastin Time), can significantly aid in the diagnosis of thrombosis and Disseminated Intravascular Coagulation (DIC). A representative from Bionote stated, "Compared to the existing 10-test kits, the 5-test format is advantageous for small clinics or environments with fewer emergency cases, making it more accessible. We anticipate that this will facilitate broader use of D-dimer products in veterinary hospitals, expanding the scope of coagulation testing." For product-related inquiries, please contact Bionote's official distributors, BioLine Co., Ltd., or Prochal Korea Co., Ltd.
The outstanding performance of Vcheck M Canine Vector 8 panel (BIONOTE) and the necessity of testing for eight pathogens simultaneously have been published in two international journals, "Journal of Veterinary Research" and the "Polish Journal of Veterinary Sciences" (Science Citation Index Expanded) Paper: J Vet Res 68, 2024 & Polish Journal of Veterinary Sciences Vol. 27, No. 2 (2024), 165– See the attached documents for the summary and click here for the full paper of J Vet Res 68, 2024 and Polish Journal of Veterinary Sciences Vol. 27, No. 2 (2024), 165– (open access). Two studies focused on monitoring vector-borne diseases in anemic dogs arriving in or returning to Poland from endemic regions, comparing results obtained using Vcheck M Canine Vector 8 (CV8) with those from real-time or conventional PCR. According to the first study, molecular tests identified vector-borne pathogens in 79 dogs. All positive results from Vcheck M CV8 were validated by standard real-time PCR with no false positives detected. Therefore, the Vcheck M CV8 provides comparable results to real-time PCR. Its capability for onsite testing is crucial for promptly detecting infections and initiating timely therapy, thereby reducing the time needed for laboratory confirmation. The second study aimed to detect Hepatozoon canis from dogs suspected of tick-borne diseases, shedding light on prevalence and clinical implications in Poland. Despite sporadic H. canis cases and infrequent R. sanguineus ticks, the study highlighted the necessity of considering H. canis in diagnosing vector-borne diseases, especially in anemic dogs in Poland. The study underscored the importance of comprehensive screening, such as with Vcheck M CV8, in identifying diverse threats, particularly amid increased travel and climate change which may introduce novel pathogens. The Vcheck M CV8 Panel is point-of-care(POC) molecular diagnostic cartridge designed for simultaneous detection of Canine Vector-borne Disease 8 pathogens: Leishmania spp., Babesia spp., Mycoplasma haemocanis, Hepatozoon spp., Ehrlichia spp., Anaplasma spp., Rickettsia rickettsii, and Bartonella spp. in canine whole blood. Learn more